Latest News
Capital Constellation has acquired a passive, minority ownership interest in Post Road Group (post Road), an alternative investment firm focused on real estate and middle-market corporate strategies, to support the Firm’s long-term growth and development.
Capital Constellation, a group of global institutional investors, who, together with Capital Constellation’s affiliated funds (collectively, “Constellation”), provides investment capital and expertise to growing investment management platforms, is managed by private equity and alternative investment manager Wafra Inc (Wafra).
Terms of the investment have not been disclosed.
The investment by Constellation follows the successful close of Post Road Special Opportunity Fund II at
Ome has secured a strategic investment from Legendary Ventures, a venture capital firm that accelerates value creation for consumer retail technology companies.
Ome will use this investment to expedite new product development and expand into new retail markets leveraging their smart home technology solutions.
Ome is a technology company focused on sustaining the home through cybernetics. Ome develops smart, sustainable technology products that automate existing home appliances so families can spend more quality time together.
Ome’s flagship product is a patented Smart Knob that seamlessly replaces existing stove knobs so people can cook, control, and monitor their home appliances virtually,
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in Safety-Reports.com, (Safety Reports).
Founded in 2011, Safety Reports provides safety and compliance management software to the construction, manufacturing and other safety-related industries. Safety Reports is an add-on to Riverside’s ToolWatch platform, a leading provider of tool tracking and construction operations management software.
By bringing the two platforms together, Riverside says customers will receive a deeper view into the performance of their organisations while providing a safer workplace and reducing time lost from safety violations.
GlacierPoint Enterprises (GlacierPoint), a portfolio company of Mill Point Capital (Mill Point) and the parent company of E&M Logistics and Jack & Jill, has partnered with A Panza & Sons (Panza), a third-generation family-owned business founded in 1965 that now stands as one of the nations’ largest full-service distributors of soft-serve ice cream mixes and related products to the retail ice cream industry.
The combined resources and operational capabilities of GlacierPoint and Panza provide a significant opportunity to scale organically and accelerate growth. Vito Panza, the son of Angelo Panza, the Company’s founder, will remain as President and his two
Macquarie Asset Management, via Macquarie European Infrastructure Fund 6, is to acquire Roadchef from Antin Infrastructure Partners.
Roadchef is a leading UK motorway service area (MSA) operator with 30 locations across the UK motorway network serving over 52 million customers every year. As the only permitted commercial presence on motorways, MSAs provide essential services to motorists, including rest areas, toilets, food and beverage outlets, refuelling/recharging facilities and accommodation.
Macquarie Asset Management intends to support Roadchef to develop and accelerate the rollout of fast-charging infrastructure for electric vehicles across its estate. Macquarie Asset Management’s investment will also enable Roadchef to invest
Latham & Watkins has advised PAI Partners and British Columbia Investment Management Corporation (BCI) in connection with the sale of a majority stake in Refresco, one of the world’s largest independent beverage contract manufacturers, to KKR.
juli, an AI-powered digital health platform focused on managing complex chronic conditions, has secured USD3.8 million in a seed funding round.
The round was led by Speedinvest, one of Europe’s most active early-stage venture capital firms, and Norrsken VC, a fund investing in start-ups solving the world’s biggest problems while building massive businesses.
SoftBank’s Vision Fund Emerge Program and Dieter Von Holtzbrinck Ventures also joined the financing round.
With a vision rooted in improving care for chronic conditions, the financing will enable juli to scale its commercial team across the US, conduct clinical trials of the app, and acquire additional
Longpoint Partners (Longpoint), a Boston-based real estate investment company, has closed its joint venture with Brookfield through its Real Estate Secondaries business.
The joint venture has recapitalised a USD700-million, 3.8 million sq ft national logistics portfolio that was held in one of Longpoint’s closed-end funds. Longpoint will maintain an interest in the portfolio and continue to manage the day-to-day operations.
The portfolio comprises 31 high quality logistics assets located in supply-constrained infill locations in high-growth markets including New Jersey, DC, Dallas, South Florida, and Boston. The assets are approximately 97 per cent leased to a diversified roster of over
Kirkland & Ellis has advised Australian private equity firm BGH Capital on the successful closing of its second vintage flagship private equity fund, BGH Capital Fund II, at approximately AUSD3.6 billion, making it the largest-ever private equity vehicle raised for deployment in Australia and New Zealand.
The fund was oversubscribed with a broad mix of global institutional investors, including sovereigns, pensions, endowments and fund of funds.
Kirkland also represented BGH Capital in raising its debut fund, BGH Capital Fund I, which was the largest first-time fund raised for Australia and New Zealand at AUD2.6 billion in 2018.
Atlas Venture, an early stage venture capital firm investing in biotech innovation, has closed its thirteenth fund, raising USD450 million in an oversubscribed fundraise.
With Fund XIII, Atlas Venture will continue working alongside talented entrepreneurs to create and invest in a new set of biotech companies aimed at delivering impactful medicines to patients.
Atlas Venture has been building and investing in innovative biotech startups for more than two decades. Since 2015, Atlas Venture has raised over USD2 billion and has created and/or invested in over 50 biotech companies. In addition to Fund XIII, Atlas is also investing from Opportunity Fund
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm